Cargando…

CD44 Upregulation in E-Cadherin-Negative Esophageal Cancers Results in Cell Invasion

E-cadherin is frequently lost during epithelial-mesenchymal transition and the progression of epithelial tumorigenesis. We found a marker of epithelial-mesenchymal transition, CD44, upregulated in response to functional loss of E-cadherin in esophageal cell lines and cancer. Loss of E-cadherin expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Le Bras, Grégoire F., Allison, Gillian L., Richards, Nicole F., Ansari, Shazia S., Washington, M. Kay, Andl, Claudia D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206075/ https://www.ncbi.nlm.nih.gov/pubmed/22069487 http://dx.doi.org/10.1371/journal.pone.0027063

Ejemplares similares

Activin a signaling regulates cell invasion and proliferation in esophageal adenocarcinoma
por: Taylor, Chase, et al.
Publicado: (2015)

Immunoexpression of E-cadherin, CD44 and Claudin 7 in gastric adenocarcinomas
por: Creţu, Oana Iulia, et al.
Publicado: (2022)

Activin A balance regulates epithelial invasiveness and tumorigenesis
por: Le Bras, Grégoire F., et al.
Publicado: (2014)

Cadherin-11 expression is upregulated in invasive human breast cancer
por: Pohlodek, Kamil, et al.
Publicado: (2016)

Prognostic significance of E-Cadherin and CD44 expression in tumor tissue of colorectal carcinoma
por: Knezevic, T, et al.
Publicado: (2015)

Augmented CPT1A Expression Is Associated with Proliferation and Colony Formation during Barrett’s Tumorigenesis
por: Bernard, Joshua N., et al.
Publicado: (2022)

Association Between the Immunohistochemistry Expression of E-cadherin, Beta-Catenin, and CD44 in Colorectal Adenocarcinoma
por: Tunuguntla, Amrutha, et al.
Publicado: (2023)

Prognostic significance of CD44 variant 2 upregulation in colorectal cancer
por: Ozawa, M, et al.
Publicado: (2014)

CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer
por: Xu, Hanxiao, et al.
Publicado: (2016)

CD44 promotes hepatocellular carcinoma progression via upregulation of YAP
por: Zhang, Jun, et al.
Publicado: (2021)

The Expression and Functional Significance of Vascular Endothelial-Cadherin, CD44, and Vimentin in Oral Squamous Cell Carcinoma
por: Irani, Soussan, et al.
Publicado: (2018)

Expression of cytotoxic T lymphocyte-associated antigen 4, CD44, and E-cadherin in the microenvironment of breast carcinomas
por: Savli, Tugce Bolme, et al.
Publicado: (2023)

YAP1 controls the N-cadherin-mediated tumor-stroma interaction in melanoma progression
por: Xio, Yao, et al.
Publicado: (2023)

Gamma secretase dependent release of the CD44 cytoplasmic tail upregulates IFI16 in cd44(-/-) tumor cells, MEFs and macrophages
por: Schultz, Kristin, et al.
Publicado: (2018)

CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity
por: Montgomery, Nicola, et al.
Publicado: (2012)

Quantitative Immunohistochemical Analyses of the Expression of E-Cadherin, Thrombomodulin, CD44H and CD44v6 in Primary Tumours of pharynx/larynx Squamous Cell Carcinoma and their Lymph Node Metastases
por: Gaspar, Rocío Hernández, et al.
Publicado: (1999)

FNDC3B circular RNA promotes the migration and invasion of gastric cancer cells via the regulation of E‐cadherin and CD44 expression
por: Hong, Yuling, et al.
Publicado: (2019)

Glycosylation of CD44 negatively regulates its recognition of hyaluronan
Publicado: (1995)

Stem-like and highly invasive prostate cancer cells expressing CD44v8-10 marker originate from CD44-negative cells
por: Di Stefano, Chiara, et al.
Publicado: (2018)

Upregulation of T-cadherin suppresses cell proliferation, migration and invasion of gastric cancer in vitro
por: Lin, Jianqing, et al.
Publicado: (2017)

SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells
por: Koumangoye, Rainelli B, et al.
Publicado: (2015)

Upregulation of cadherin‐11 contributes to cholestatic liver fibrosis
por: Wu, Bo, et al.
Publicado: (2022)

Prognostic Value of E-cadherin-, CD44-, and MSH2-associated Nomograms in Patients With Stage II and III Colorectal Cancer
por: Qu, Jinmiao, et al.
Publicado: (2017)

Differential expression of Oct-4, CD44, and E-cadherin in eutopic and ectopic endometrium in ovarian endometriomas and their correlations with clinicopathological variables
por: Sancakli Usta, Ceyda, et al.
Publicado: (2020)

Meta-Analysis of Prognostic and Clinical Significance of CD44v6 in Esophageal Cancer
por: Hu, Bangli, et al.
Publicado: (2015)

CD44 Targeted Nanomaterials for Treatment of Triple-Negative Breast Cancer
por: Nabil, Ghazal, et al.
Publicado: (2021)

Upregulation of SALL4 by EGFR activation regulates the stemness of CD44-positive lung cancer
por: Du, Wenjing, et al.
Publicado: (2018)

CD44 cross-linking increases malignancy of breast cancer via upregulation of p-Moesin
por: Hu, Song, et al.
Publicado: (2020)

Activation of the mTOR pathway promotes neurite growth through upregulation of CD44 expression
por: Zhang, Jiwei, et al.
Publicado: (2023)

Esophageal squamous cell carcinoma invasion is inhibited by Activin A in ACVRIB-positive cells
por: Loomans, Holli A., et al.
Publicado: (2016)

Tumor Initiating Cells in Esophageal Squamous Cell Carcinomas Express High Levels of CD44
por: Zhao, Jiang-Sha, et al.
Publicado: (2011)

Expression analysis of CD44 isoforms S and V3, in patients with esophageal squamous cell carcinoma
por: Mansouri, Atena, et al.
Publicado: (2015)

The liberation of CD44
por: Cichy, Joanna, et al.
Publicado: (2003)

DACH1 suppresses breast cancer as a negative regulator of CD44
por: Xu, Hanxiao, et al.
Publicado: (2017)

Phototheranostics of CD44-positive cell populations in triple negative breast cancer
por: Jin, Jiefu, et al.
Publicado: (2016)

Expression of RSK4, CD44 and MMP-9 is upregulated and positively correlated in metastatic ccRCC
por: Ma, Jing, et al.
Publicado: (2020)

A Systematic Review to Clarify the Prognostic Values of CD44 and CD44(+)CD24(-) Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead
por: Abdoli Shadbad, Mahdi, et al.
Publicado: (2021)

CD44s and CD44v6 Expression in Head and Neck Epithelia
por: Mack, Brigitte, et al.
Publicado: (2008)

Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan
Publicado: (1996)

CD44(+)/CD24(−) phenotype predicts a poor prognosis in triple-negative breast cancer
por: Wang, Hui, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3re3e48tica5fhbigv580q6ko8